Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN201781 in Neuropathic Pain
NCT00533351Phase 2Terminated
- Sponsor
- Allergan
- Start
- Mar 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of AGN201781 in postherpetic neuralgia (PHN), sponsored by Allergan. Started Mar 2008; status: terminated.
02
Drugs
AGN201781
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00533351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533351.